KLK3 and prostate carcinoma: In this study, we evaluated biochemical recurrence free survival (RFS) – as defined by the rate of patients without prostate specific antigen (PSA) relapse over time after radical prostatectomy (RP) – according to the preoperative BKPyV serostatus of primary prostate cancer patients.